The fact that eEF1A2 is not expressed in the normal liver but its expression is pathologically turned on during HCC development, suggests that an anti eEF1A2 siRNA may exert its effect in HCC cells but not in normal hepatocytes. This evidence concerns the gene EEF1A2 and hepatocellular carcinoma.